{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:39:59Z","timestamp":1793097599605,"version":"4.5.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["155\\u2013159"],"award-info":[{"award-number":["155\\u2013159"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00336744"],"award-info":[{"award-number":["RS-2024-00336744"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainstimjrnl.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Stimulation"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.brs.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:54:52Z","timestamp":1744347292000},"page":"909-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic review for VNS vs. pharmaceutical modulations for multifaceted neurological disorder management through cross-case, network meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0756-4382","authenticated-orcid":false,"given":"Hyun-Jee","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakseung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brs.2025.04.007_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0301-0082(97)00050-6","article-title":"Diffuse transmission by acetylcholine in the CNS","volume":"53","author":"Descarries","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.brs.2025.04.007_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-23274-9_2","article-title":"Structure-function studies of muscarinic acetylcholine receptors","volume":"208","author":"Leach","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2014.00020","article-title":"Acetylcholine release and inhibitory interneuron activity in hippocampal CA1","volume":"6","author":"McQuiston","year":"2014","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1113\/jphysiol.1971.sp009467","article-title":"The mechanism of excitation by acetylcholine in the cerebral cortex","volume":"215","author":"Krnjevi\u0107","year":"1971","journal-title":"J Physiol"},{"key":"10.1016\/j.brs.2025.04.007_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1139\/y86-056","article-title":"Choline analogues: their use in studies of acetylcholine synthesis, storage, and release","volume":"64","author":"Collier","year":"1986","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1566-0702(00)00215-0","article-title":"Functional and chemical anatomy of the afferent vagal system","volume":"85","author":"Berthoud","year":"2000","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-8993(67)90089-3","article-title":"Afferent vagal stimulation: neurographic correlates of induced EEG synchronization and desynchronization","volume":"5","author":"Chase","year":"1967","journal-title":"Brain Res"},{"key":"10.1016\/j.brs.2025.04.007_bib9","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.brs.2025.04.007_bib8","unstructured":"SyRF - Systematic Review Facility. https:\/\/syrf.org.uk\/."},{"key":"10.1016\/j.brs.2025.04.007_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00204-012-0977-1","article-title":"The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors","volume":"87","author":"Soukup","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.brs.2025.04.007_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1615\/CritRevNeurobiol.v10.i1.40","article-title":"Molecular biology of muscarinic acetylcholine receptors","volume":"10","author":"Wess","year":"1996","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.brs.2025.04.007_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0003-9861(86)90601-6","article-title":"Acetylcholinesterase: theory of noncompetitive inhibition","volume":"247","author":"Froede","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.brs.2025.04.007_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jcc.20199","article-title":"Theoretical insights into the mechanism of acetylcholinesterase-catalyzed acylation of acetylcholine","volume":"26","author":"Manojkumar","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.brs.2025.04.007_bib14","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1110\/ps.03318603","article-title":"Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach","volume":"12","author":"Kua","year":"2003","journal-title":"Protein Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system: a relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-6147(89)90231-9","article-title":"Mechanism of action of scopolamine as an amnestic","volume":"10","author":"Izquierdo","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000325171","article-title":"Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study","volume":"31","author":"Sittironnarit","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.brs.2025.04.007_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review","volume":"43","author":"Fox","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.brs.2025.04.007_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.brs.2025.04.007_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0031-9384(68)90121-2","article-title":"Cortical and subcortical EEG patterns of response to afferent abdominal vagal stimulation: neurographic correlates","volume":"3","author":"Chase","year":"1968","journal-title":"Physiol Behav"},{"key":"10.1016\/j.brs.2025.04.007_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-8993(67)90089-3","article-title":"Afferent vagal stimulation: neurographic correlates of induced EEG synchronization and desynchronization","volume":"5","author":"Chase","year":"1967","journal-title":"Brain Res"},{"key":"10.1016\/j.brs.2025.04.007_bib23","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.neuron.2022.06.017","article-title":"Vagus nerve stimulation drives selective circuit modulation through cholinergic reinforcement","volume":"110","author":"Bowles","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.brs.2025.04.007_bib81","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.brs.2025.04.007_bib82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017126","article-title":"The effects of donepezil in Alzheimer's disease - results from a multinational trial","volume":"10","author":"Burns","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.brs.2025.04.007_bib83","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/gps.1746","article-title":"Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease","volume":"22","author":"Burns","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjopharm.2005.02.001","article-title":"Is donepezil therapy associated with reduced mortality in nursing home residents with dementia?","volume":"3","author":"Gasper","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.brs.2025.04.007_bib85","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brs.2025.04.007_bib86","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3233\/JAD-161117","article-title":"Efficacy and safety of donepezil in Chinese patients with severe Alzheimer's disease: a randomized controlled trial","volume":"56","author":"Jia","year":"2017","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.brs.2025.04.007_bib87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.57.3.481","article-title":"A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients","volume":"57","author":"Mohs","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib88","first-page":"1590","article-title":"A randomized, double\u2010blind, placebo\u2010controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting","volume":"49","author":"Tariot","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.brs.2025.04.007_bib89","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","article-title":"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","volume":"367","author":"Winblad","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.brs.2025.04.007_bib90","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/gps.1788","article-title":"A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule","volume":"22","author":"Winblad","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib91","first-page":"391","article-title":"Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease","volume":"10","author":"Hager","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.brs.2025.04.007_bib92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.trci.2019.07.011","article-title":"Are antidementia drugs associated with reduced mortality after a hospital emergency admission in the population with dementia aged 65 years and older?","volume":"5","author":"Hapca","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.brs.2025.04.007_bib93","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0269881119845795","article-title":"The effect of antidementia drugs on mortality in patients with Alzheimer's disease","volume":"33","author":"Lin","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.72.3.310","article-title":"Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease","volume":"72","author":"Lopez","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib95","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JGP.0b013e3181e56d30","article-title":"Cholinesterase inhibitors for alzheimer disease: do they provide more than symptomatic benefits?","volume":"19","author":"Suh","year":"2011","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.brs.2025.04.007_bib96","first-page":"69","article-title":"Effect of acetylcholinesterase inhibitors on post-surgical complications and mortality following a hip fracture: a cohort study","volume":"17","author":"Tamimi","year":"2017","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.brs.2025.04.007_bib97","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.brs.2025.04.007_bib98","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","article-title":"Topiramate in migraine prevention: results of a large controlled trial","volume":"61","author":"Silberstein","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib99","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.clinthera.2006.07.003","article-title":"Efficacy and tolerability of topiramate 200 mg\/d in the prevention of migraine with\/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study","volume":"28","author":"Silberstein","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.brs.2025.04.007_bib100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.clinthera.2007.05.008","article-title":"The cycle of migraine: patients' quality of life during and between migraine attacks","volume":"29","author":"Freitag","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.brs.2025.04.007_bib101","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/WNL.44.4.647","article-title":"Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study","volume":"44","author":"Jensen","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib102","article-title":"Study of visual function in adult epileptic patients on sodium valproate or carbamazepine monotherapy","volume":"11","author":"Matthew","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.brs.2025.04.007_bib103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.1992.hed3202101.x","article-title":"Fluoxetine prophylaxis of migraine","volume":"32","author":"Adly","year":"1992","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.brs.2025.04.007_bib104","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1526-4610.1999.3910716.x","article-title":"Fluoxetine for migraine prophylaxis: a double-blind trial","volume":"39","author":"Colucci D'Amato","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"Saper","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1468-2982.1998.1805283.x","article-title":"S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study","volume":"18","author":"Steiner","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1016\/j.brs.2025.04.007_bib107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.51.1.48","article-title":"Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial","volume":"51","author":"Handforth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib35","first-page":"1265","article-title":"An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome","volume":"43","author":"Amar","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.brs.2025.04.007_bib108","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.52.6.1265","article-title":"Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years","volume":"52","author":"Ben-Menachem","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1212\/WNL.52.7.1510","article-title":"Vagus nerve stimulation for medication-resistant generalized epilepsy","volume":"52","author":"Labar","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib37","article-title":"Cost-benefit of vagus nerve stimulation for refractory epilesy","volume":"99","author":"Boon","year":"1999","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.brs.2025.04.007_bib109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/01.wnl.0000168899.11598.00","article-title":"Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms","volume":"65","author":"DeGiorgio","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib110","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1212\/WNL.53.8.1731","article-title":"Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy","volume":"53","author":"Morris","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000029764","article-title":"Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial","volume":"73","author":"Amar","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.brs.2025.04.007_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00004691-200109000-00004","article-title":"Vagus nerve stimulation: clinical experience in a large patient series","volume":"18","author":"Scherrmann","year":"2001","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.brs.2025.04.007_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0303-8467(02)00018-5","article-title":"Vagus nerve stimulation for treatment of medically intractable seizures. Evaluation of long-term outcome","volume":"105","author":"Tanganelli","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.brs.2025.04.007_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1525-5050(03)00109-4","article-title":"Long-term outcome of vagus nerve stimulation for refractory partial epilepsy","volume":"4","author":"Chavel","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.brs.2025.04.007_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.WNP.0000139654.32974.4E","article-title":"Vagus nerve stimulation for refractory epilepsy: a transatlantic experience","volume":"21","author":"Vonck","year":"2004","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.brs.2025.04.007_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yebeh.2005.01.009","article-title":"Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities","volume":"6","author":"Huf","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.brs.2025.04.007_bib42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.seizure.2006.09.006","article-title":"Effects of two different cycles of vagus nerve stimulation on interictal epileptiform discharges","volume":"15","author":"Santiago-Rodr\u00edguez","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.seizure.2007.04.005","article-title":"Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study","volume":"16","author":"Ardesch","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib112","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2007.01.008","article-title":"Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study","volume":"11","author":"De Herdt","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jocn.2007.07.083","article-title":"Long-term outcome of vagus nerve stimulation therapy in patients with refractory epilepsy","volume":"15","author":"Abubakr","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2009.04.012","article-title":"Long-term effect of vagus nerve stimulation on interictal epileptiform discharges in refractory epilepsy","volume":"284","author":"Wang","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yebeh.2009.08.018","article-title":"Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery","volume":"16","author":"Elliott","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.brs.2025.04.007_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1528-1167.2010.02620.x","article-title":"Outcome of vagus nerve stimulation for epilepsy in Budapest","volume":"51","author":"M\u00fcller","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.brs.2025.04.007_bib113","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.seizure.2010.03.002","article-title":"Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up","volume":"19","author":"Ghaemi","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2176\/nmc.ra.2014-0405","article-title":"Vagus nerve stimulation therapy: indications, programing, and outcomes","volume":"55","author":"Yamamoto","year":"2015","journal-title":"Neurol Med -Chir"},{"key":"10.1016\/j.brs.2025.04.007_bib115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2017.03.020","article-title":"Predicting success of vagus nerve stimulation (VNS) from EEG symmetry","volume":"48","author":"Hilderink","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib116","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2019.07.006","article-title":"Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy","volume":"71","author":"Tzadok","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib117","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/ene.14270","article-title":"Neurophysiological investigations of drug resistant epilepsy patients treated with vagus nerve stimulation to differentiate responders from non-responders","volume":"27","author":"H\u00f6dl","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1210221","article-title":"Predictive factors for successful vagus nerve stimulation in patients with refractory epilepsy: real-life insights from a multicenter study","volume":"17","author":"Pires do Prado","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib119","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex activation therapy for the treatment of heart failure with a ReducedEjection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.brs.2025.04.007_bib120","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","article-title":"Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy for Heart Failure (NECTAR-HF) randomized controlled trial","volume":"36","author":"Zannad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.brs.2025.04.007_bib121","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","article-title":"Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial","volume":"68","author":"Gold","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.brs.2025.04.007_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction","volume":"76","author":"Zile","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.brs.2025.04.007_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-015-0543-3","article-title":"Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial","volume":"16","author":"Straube","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.brs.2025.04.007_bib124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","article-title":"Established antiepileptic drugs","volume":"6","author":"Brodie","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"G Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.brs.2025.04.007_bib126","unstructured":"S1-2. Epilepsy and the autonomic nervous system: UPDATE - ScienceDirect. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1388245718301275."},{"key":"10.1016\/j.brs.2025.04.007_bib127","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.410340221","article-title":"Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I\u2010iododexetimide and single\u2010photon emission computed tomography in epilepsy","volume":"34","author":"M\u00fcller\u2010G\u00e4rtner","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib128","article-title":"Cholinergic signaling, neural excitability, and epilepsy","author":"Wang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.brs.2025.04.007_bib29","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.52.6.1265","article-title":"Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years","volume":"52","author":"Ben-Menachem","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/01.wnl.0000168899.11598.00","article-title":"Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms","volume":"65","author":"DeGiorgio","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(94)00083-9","article-title":"Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures","volume":"20","author":"Ben-Menachem","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.brs.2025.04.007_bib131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3760\/cma.j.issn.0366-6999.20131511","article-title":"An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation","volume":"127","author":"Rong","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.brs.2025.04.007_bib132","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.seizure.2019.06.026","article-title":"Sustained seizure freedom with transcutaneous vagal nerve stimulation in drug-resistant epilepsy caused by subcortical band heterotopias","volume":"70","author":"von Wrede","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib133","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.brs.2015.11.003","article-title":"Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02)","volume":"9","author":"Bauer","year":"2016","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2025.04.007_bib134","doi-asserted-by":"crossref","first-page":"8439","DOI":"10.12659\/MSM.910689","article-title":"Efficacy and safety of treatment with transcutaneous vagus nerve stimulation in 17 patients with refractory epilepsy evaluated by electroencephalogram, seizure frequency, and quality of life","volume":"24","author":"Liu","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.brs.2025.04.007_bib135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.seizure.2018.06.016","article-title":"Transcutaneous vagal nerve stimulatio (t-VNS): an adjunctive treatment option for refractory epilepsy","volume":"60","author":"Barbella","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib136","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11517-023-02914-y","article-title":"Dynamical graph neural network with attention mechanism for epilepsy detection using single channel EEG","volume":"62","author":"Li","year":"2024","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.brs.2025.04.007_bib137","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.seizure.2014.02.012","article-title":"Ictal tachycardia: the head-heart connection","volume":"23","author":"Eggleston","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.seizure.2019.07.006","article-title":"Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy","volume":"71","author":"Tzadok","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.brs.2025.04.007_bib139","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2106166","article-title":"Cranial autonomic symptoms and migraine: what relationship and what meaning? A review","volume":"21","author":"Cascio","year":"2022","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.brs.2025.04.007_bib141","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s00415-023-11706-1","article-title":"Migraine: from pathophysiology to treatment","volume":"270","author":"Puledda","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib142","doi-asserted-by":"crossref","first-page":"185","DOI":"10.31083\/j.jin.2021.01.313","article-title":"The role of mast cells in the gut and brain","volume":"20","author":"Traina","year":"2021","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib143","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-017-0807-1","article-title":"Blocking CGRP in migraine patients \u2013 a review of pros and cons","volume":"18","author":"Deen","year":"2017","journal-title":"J Headache Pain"},{"key":"10.1016\/j.brs.2025.04.007_bib144","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/head.13042","article-title":"Are blurred vision and short-duration visual phenomena migraine aura symptoms?","volume":"57","author":"Friedman","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.50.2.228","article-title":"Pupil diameter in migraine and tension headache","volume":"50","author":"Drummond","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib146","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2003.04.004","article-title":"Topiramate-associated acute, bilateral, secondary angle-closure glaucoma","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brs.2025.04.007_bib147","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2165\/00003495-199754050-00009","article-title":"A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy","volume":"54","author":"Langtry","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.brs.2025.04.007_bib148","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/106002809703101010","article-title":"Topiramate: a new antiepileptic drug","volume":"31","author":"Privitera","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.brs.2025.04.007_bib149","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ane.13528","article-title":"Meta-analysis of association between migraine and risk of dementia","volume":"145","author":"Wang","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.brs.2025.04.007_bib150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","article-title":"The efficacy and safety of venlafaxine in the prophylaxis of migraine","volume":"45","author":"Ozyalcin","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911418","article-title":"Migraine pharmacological treatment and cognitive impairment: risks and benefits","volume":"23","author":"Russo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib152","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00210-013-0866-z","article-title":"Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice","volume":"386","author":"Biala","year":"2013","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib153","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1526-4610.1991.hed3106388.x","article-title":"Flunarizine in migraine: a minireview","volume":"31","author":"Leone","year":"1991","journal-title":"Headache"},{"issue":"2 3","key":"10.1016\/j.brs.2025.04.007_bib154","first-page":"131","article-title":"Efficacy of memantine compared with sodium valproate as prophylactic treatment for migraine: a controlled randomized pilot study","volume":"3","author":"Vazquez-Guevara","year":"2019","journal-title":"Open Exploration"},{"key":"10.1016\/j.brs.2025.04.007_bib155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ncn3.12053","article-title":"Effectiveness and safety of an extended-release tablet of sodium valproate for the prophylactic treatment of migraine: postmarketing surveillance in Japan","volume":"4","author":"Takeshima","year":"2016","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib156","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.24911\/IJMDC.51-1728900894","article-title":"Efficacy and safety of oral propranolol versus sodium valproate in prophylaxis of migraine: a systematic review and meta-analysis","author":"Shaqran","year":"2024","journal-title":"International Journal of Medicine in Developing Countries"},{"key":"10.1016\/j.brs.2025.04.007_bib157","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0006-3223(99)00028-1","article-title":"Sodium valproate increases pupillary responsiveness to a cholinergic agonist in responders with mania","volume":"46","author":"Demet","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib159","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib160","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1007\/s12325-021-01897-2","article-title":"Mapping migraine-specific quality of life to health state utilities in patients receiving rimegepant","volume":"38","author":"Johnston","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.brs.2025.04.007_bib161","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1526-4610.1999.3902108.x","article-title":"Autonomic dysfunction in migraineurs","volume":"39","author":"Mosek","year":"1999","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib162","article-title":"Parasympathetic cholinergic and neuropeptide mechanisms of migraine","volume":"7","author":"Mikhailov","year":"2017","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.brs.2025.04.007_bib55","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0333102414524494","article-title":"Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study","volume":"34","author":"Goadsby","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.brs.2025.04.007_bib163","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1526-4610.2007.00994.x","article-title":"Heart rate recovery in migraine and tension-type headache","volume":"48","author":"Yerdelen","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.brs.2025.04.007_bib164","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0333102414524494","article-title":"Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study","volume":"34","author":"Goadsby","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.brs.2025.04.007_bib165","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","article-title":"Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study","volume":"91","author":"Tassorelli","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.brs.2025.04.007_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2021.102875","article-title":"tVNS in the management of headache and pain","volume":"236","author":"Straube","year":"2021","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101971","article-title":"Transcutaneous auricular vagus nerve stimulation at 1 Hz modulates locus coeruleus activity and resting state functional connectivity in patients with migraine: an fMRI study","volume":"24","author":"Zhang","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.brs.2025.04.007_bib168","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/1533317512459792","article-title":"Clinical and functional assessment of dysautonomia and its correlation in Alzheimer's disease","volume":"27","author":"Zakrzewska-Pniewska","year":"2012","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.brs.2025.04.007_bib169","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-150169","article-title":"Autonomic dysfunction in patients with mild to moderate Alzheimer's disease","volume":"47","author":"Jensen-Dahm","year":"2015","journal-title":"J Alzheim Dis"},{"key":"10.1016\/j.brs.2025.04.007_bib170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/3729","article-title":"Plasticity of temporal information processing in the primary auditory cortex","volume":"1","author":"Kilgard","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109545","article-title":"Crosstalk between the M1 muscarinic acetylcholine receptor and the endocannabinoid system: a relevance for Alzheimer's disease?","volume":"70","author":"Thompson","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.brs.2025.04.007_bib172","article-title":"Neuroprotective and neurotoxic implications of \u03b17 nicotinic acetylcholine receptor and a\u00df interaction: therapeutic options in Alzheimer's disease","volume":"18","author":"Farhat","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.brs.2025.04.007_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00309","article-title":"Alzheimer's disease as a membrane disorder: spatial cross-talk among beta-amyloid peptides, nicotinic acetylcholine receptors and lipid rafts","volume":"13","author":"Fabiani","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib174","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1523\/JNEUROSCI.4985-04.2005","article-title":"Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site","volume":"25","author":"Akk","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib175","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.brs.2025.04.007_bib176","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archneur.61.2.252","article-title":"The cognitive benefits of galantamine are sustained for at least 36 Months: a long-term extension trial","volume":"61","author":"Raskind","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib177","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1155\/1999\/168023","article-title":"Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease","volume":"11","author":"Rosler","year":"1998","journal-title":"Behav Neurol"},{"key":"10.1016\/j.brs.2025.04.007_bib178","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.318.7184.633","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial","volume":"318","author":"Rosler","year":"1999","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.brs.2025.04.007_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-5-25","article-title":"Alzheimers disease A\u03b2 assemblies mediating rapid disruption of synaptic plasticity and memory","volume":"5","author":"Klyubin","year":"2012","journal-title":"Mol Brain"},{"key":"10.1016\/j.brs.2025.04.007_bib180","first-page":"5261","article-title":"Vagus nerve stimulation activates nucleus of solitary tract neurons via supramedullary pathways","volume":"599","author":"Cooper","year":"2021","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.brs.2025.04.007_bib181","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease","volume":"15","author":"Bari","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.brs.2025.04.007_bib182","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4088\/JCP.v63n1103","article-title":"Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study","volume":"63","author":"Sj\u00f6gren","year":"2002","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/j.brs.2025.04.007_bib183","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.96.11.6400","article-title":"Low- and high-level transgenic expression of \u03b22-adrenergic receptors differentially affect cardiac hypertrophy and function in G\u03b1q-overexpressing mice","volume":"96","author":"Dorn","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.brs.2025.04.007_bib184","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","article-title":"Dual modulation of cell survival and cell death by \u03b22-adrenergic signaling in adult mouse cardiac myocytes","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.brs.2025.04.007_bib185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2008.11.057","article-title":"A vasodilating selective \u03b21-blocker, is a \u03b23-adrenoceptor agonist in the nonfailing transplanted human heart","volume":"53","author":"Rozec","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.brs.2025.04.007_bib186","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12576-009-0071-5","article-title":"Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure","volume":"60","author":"Okazaki","year":"2010","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib187","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.2654","article-title":"Potential cardioprotective effects of acetylcholinesterase inhibitors in patients with Alzheimer's disease","volume":"44","author":"Rampa","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.brs.2025.04.007_bib188","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0002-8703(03)00319-3","article-title":"Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure","volume":"146","author":"Behling","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.brs.2025.04.007_bib189","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/eurjhf\/hft118","article-title":"Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure","volume":"15","author":"Hamann","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.brs.2025.04.007_bib190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autneu.2006.01.009","article-title":"Signalling the state of the digestive tract","volume":"125","author":"Grundy","year":"2006","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib191","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2362.2007.01887.x","article-title":"Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease","volume":"37","author":"Coruzzi","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.brs.2025.04.007_bib192","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000116774","article-title":"Role of the brain-gut axis in the pathophysiology of Crohn's disease","volume":"26","author":"Stasi","year":"2008","journal-title":"Dig Dis"},{"key":"10.1016\/j.brs.2025.04.007_bib193","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/apt.14422","article-title":"Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis","volume":"47","author":"Singh","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.brs.2025.04.007_bib194","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0803237105","article-title":"Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia","volume":"105","author":"Rosas-Ballina","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.brs.2025.04.007_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.650971","article-title":"Therapeutic potential of vagus nerve stimulation for inflammatory bowel diseases","volume":"15","author":"Bonaz","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.brs.2025.04.007_bib68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biopsych.2005.07.028","article-title":"A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression","volume":"58","author":"George","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib198","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11126-020-09726-5","article-title":"Adjunctive vagus nerve stimulation for treatment-resistant depression: a quantitative analysis","volume":"91","author":"Zhang","year":"2020","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.brs.2025.04.007_bib199","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8885729","article-title":"Effects of transcutaneous auricular vagus nerve stimulation on peripheral and central tumor necrosis factor alpha in rats with depression-chronic somatic pain comorbidity","volume":"2020","author":"Guo","year":"2020","journal-title":"Neural Plast"},{"key":"10.1016\/j.brs.2025.04.007_bib200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2215-0366(16)00012-2","article-title":"Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study","volume":"3","author":"Shilyansky","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.brs.2025.04.007_bib201","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-009-0073-3","article-title":"Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data","volume":"30","author":"Proietti Cecchini","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.brs.2025.04.007_bib202","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/j.pain.0000000000000437","article-title":"Vagus nerve stimulation inhibits cortical spreading depression","volume":"157","author":"Chen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.brs.2025.04.007_bib69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-012-0908-6","article-title":"Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study","volume":"120","author":"Hein","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.brs.2025.04.007_bib70","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2016.02.031","article-title":"Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study","volume":"195","author":"Rong","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.007_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.brs.2016.02.001","article-title":"Transcutaneous vagus nerve stimulation (taVNS) for major depressive disorder: an open label proof-of-concept trial","volume":"9","author":"Trevizol","year":"2016","journal-title":"Brain Stimul"},{"key":"10.1016\/j.brs.2025.04.007_bib72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neurom.2021.10.021","article-title":"Comparative effectiveness of transcutaneous auricular vagus nerve stimulation vs citalopram for major depressive disorder: a randomized trial","volume":"25","author":"Li","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/j.brs.2025.04.007_bib203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ner.13528","article-title":"A comprehensive review of vagus nerve stimulation for depression","volume":"25","author":"Austelle","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/j.brs.2025.04.007_bib73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2024.03.005","article-title":"Transcutaneous auricular vagus nerve stimulation for post-stroke depression: a double-blind, randomized, placebo-controlled trial","volume":"354","author":"Liu","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.brs.2025.04.007_bib204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ped4.12198","article-title":"Efficacy and brain mechanism of transcutaneous auricular vagus nerve stimulation for adolescents with mild to moderate depression: study protocol for a randomized controlled trial","volume":"4","author":"Xiao","year":"2020","journal-title":"Pediatr Investig"},{"key":"10.1016\/j.brs.2025.04.007_bib205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.psychres.2017.04.006","article-title":"Pain and multiple facets of anger and hostility in a sample seeking treatment for problematic anger","volume":"253","author":"McDermott","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.brs.2025.04.007_bib206","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.bjp.0703268","article-title":"Loss of muscarinic antinociception by antisense inhibition of M(1) receptors","volume":"129","author":"Ghelardini","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.brs.2025.04.007_bib207","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/157488911795933901","article-title":"Analgesic and antineuropathic drugs acting through central cholinergic mechanisms","volume":"6","author":"Bartolini","year":"2011","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.brs.2025.04.007_bib208","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/JPR.S190231","article-title":"Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review","volume":"12","author":"Di Stefano","year":"2019","journal-title":"J Pain Res"},{"key":"10.1016\/j.brs.2025.04.007_bib80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5606\/tftrd.2020.3225","article-title":"The efficacy of transcutaneous electrical nerve stimulation therapy in pain control after cesarean section delivery associated with uterine contractions and abdominal incision","volume":"66","author":"Kasapo\u011flu","year":"2020","journal-title":"Turk J Phys Med Rehabil"},{"key":"10.1016\/j.brs.2025.04.007_bib79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1526-4637.2012.01385.x","article-title":"Evoked pain analgesia in chronic pelvic pain patients using respiratory-gated auricular vagal afferent nerve stimulation","volume":"13","author":"Napadow","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/j.brs.2025.04.007_bib209","article-title":"Acetyl-l-carnitine for the treatment of diabetic peripheral neuropathy","volume":"2019","author":"Rolim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.brs.2025.04.007_bib210","article-title":"Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor-alpha","volume":"29","author":"Brock","year":"2017","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.brs.2025.04.007_bib211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0976-9668.107254","article-title":"Vagal nerve stimulator: evolving trends","volume":"4","author":"Ogbonnaya","year":"2013","journal-title":"J Nat Sci Biol Med"}],"container-title":["Brain Stimulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1935861X25000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:33:57Z","timestamp":1762562037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X25000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1935861X25000889"],"URL":"https:\/\/doi.org\/10.1016\/j.brs.2025.04.007","relation":{},"ISSN":["1935-861X"],"issn-type":[{"value":"1935-861X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review for VNS vs. pharmaceutical modulations for multifaceted neurological disorder management through cross-case, network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain Stimulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brs.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}